• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study

    Credits

    1 Contact Hour(s)

    Release Date

    Tuesday, August 1, 2017

    Offline Date

    Saturday, August 1, 2020

    ACPE Expiration Date

    Saturday, August 1, 2020

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      The Health Insurance Portability and Accountability Act (HIPAA) is an important legal protection of an individuals rights to privacy and security of their health information. The Final Omnibus Rule posed important modifications to the existing rule to strengthen and simplify many aspects of HIPAA. This knowledge based activity will serve as a summary of the major modifications to HIPAA following adoption of the Final Omnibus Rule and highlight key enforcement issues reported by the Department of Health and Human Services.

      Rating

         4.25  out of 5

      Handouts

      • Homestudy PDF :   HomestudyPDF_17174H03.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Describe how business associates and marketing/fundraising communications are affected by the Final Omnibus Rule
      Recognize the modification of breach notifications regarding the utilization of risk assessment rather than the risk of harm standard
      Identify the strengths that the modifications add to the Notice of Privacy Practices
      Utilizing enforcement data, recognize the most commonly investigated compliance issues and the most common types of covered entities requiring corrective action

      Pharmacy Technician

      Identify the strengths that the modifications add to the Notice of Privacy Practices
      Recognize the modification of breach notifications regarding the utilization of risk assessment rather than the risk of harm standard
      Describe how business associates and marketing/fundraising communications are affected by the Final Omnibus Rule
      Utilizing enforcement data, recognize the most commonly investigated compliance issues and the most common types of covered entities requiring corrective action

      Nurse

      Describe how business associates and marketing/fundraising communications are affected by the Final Omnibus Rule
      Identify the strengths that the modifications add to the Notice of Privacy Practices
      Recognize the modification of breach notifications regarding the utilization of risk assessment rather than the risk of harm standard
      Utilizing enforcement data, recognize the most commonly investigated compliance issues and the most common types of covered entities requiring corrective action
    • Activity Type

      Knowledge

      CE Broker

      20-583971

      Universal Activity Number

      Pharmacist 0798-0000-17-174-H03-P
      Pharmacy Technician 0798-0000-17-174-H03-T
      Nurse 0798-0000-17-174-H03-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).